RAVAGLIA, SABRINA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.042
AS - Asia 1.901
EU - Europa 1.877
SA - Sud America 232
Continente sconosciuto - Info sul continente non disponibili 75
AF - Africa 60
OC - Oceania 6
Totale 7.193
Nazione #
US - Stati Uniti d'America 2.940
CN - Cina 891
SG - Singapore 435
IE - Irlanda 372
IT - Italia 369
DE - Germania 230
HK - Hong Kong 222
FI - Finlandia 201
RU - Federazione Russa 194
VN - Vietnam 182
UA - Ucraina 173
BR - Brasile 165
GB - Regno Unito 107
FR - Francia 81
CA - Canada 37
IN - India 37
SE - Svezia 36
ZA - Sudafrica 31
BD - Bangladesh 29
EC - Ecuador 19
BE - Belgio 18
AR - Argentina 17
NL - Olanda 17
JP - Giappone 16
ES - Italia 15
PL - Polonia 15
MX - Messico 13
GT - Guatemala 10
IQ - Iraq 10
MA - Marocco 10
PK - Pakistan 10
CL - Cile 7
CO - Colombia 7
CR - Costa Rica 7
MY - Malesia 7
AT - Austria 6
CZ - Repubblica Ceca 6
ID - Indonesia 6
LT - Lituania 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
VE - Venezuela 6
AU - Australia 5
CH - Svizzera 5
JM - Giamaica 5
KR - Corea 5
SA - Arabia Saudita 5
TN - Tunisia 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
ET - Etiopia 4
GP - Guadalupe 4
GR - Grecia 4
HN - Honduras 4
JO - Giordania 4
NI - Nicaragua 4
PE - Perù 4
PT - Portogallo 4
BH - Bahrain 3
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
PH - Filippine 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
AZ - Azerbaigian 2
EG - Egitto 2
KH - Cambogia 2
KW - Kuwait 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
Totale 7.123
Città #
Chandler 376
Dublin 369
San Jose 288
Singapore 258
Ashburn 256
Dallas 226
Hong Kong 215
Jacksonville 206
Beijing 188
Nanjing 164
Council Bluffs 145
Boardman 121
Milan 80
Helsinki 79
Los Angeles 78
Munich 73
Ho Chi Minh City 67
Nanchang 60
Lauterbourg 53
New York 53
Ann Arbor 52
Jiaxing 52
Pavia 52
Changsha 51
Lawrence 50
Princeton 50
Medford 49
Hebei 48
Hanoi 44
Wilmington 43
Shenyang 41
Shanghai 35
Buffalo 34
Hangzhou 33
Turku 30
Johannesburg 28
Moscow 28
Santa Clara 21
Tianjin 21
Frankfurt am Main 19
London 18
São Paulo 18
Brussels 17
Rome 17
Atlanta 16
Redondo Beach 16
Tokyo 16
Trieste 15
Verona 15
Brooklyn 14
Orem 14
Toronto 13
Turin 13
Warsaw 13
Bergamo 12
Denver 12
Montreal 11
Seattle 11
Amsterdam 10
Columbus 10
Da Nang 10
The Dalles 10
Woodbridge 10
Manchester 9
Naples 9
San Francisco 9
Charlotte 8
Chicago 8
Florence 8
Guatemala City 8
Houston 8
Cagliari 7
Chennai 7
Dhaka 7
Falkenstein 7
Modena 7
Nuremberg 7
Piscataway 7
Poplar 7
Pune 7
Stockholm 7
Biên Hòa 6
Bologna 6
Gorlago 6
Kunming 6
Lahore 6
Lodi 6
Mexico City 6
North Bergen 6
Norwalk 6
Phoenix 6
San José 6
Belo Horizonte 5
Boston 5
Brescia 5
Brno 5
Chaguanas 5
Fairfield 5
Guayaquil 5
Haiphong 5
Totale 4.690
Nome #
Mapping the human genetic architecture of COVID-19 312
A first update on mapping the human genetic architecture of COVID-19 230
A Chaperone Enhances Blood α-Glucosidase Activity in Pompe Disease Patients Treated With Enzyme Replacement Therapy. 167
Changes in nutritional status and body composition during enzyme replacementtherapy in adult-onset type II glycogenosis. 152
Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant. 150
Dietary treatment in adult-onset type II glycogenosis. 146
Enzyme replacement therapy (ERT) in adult-onset type II glycogenosis (GSDII) 139
Cognitive impairment and central motor conduction time in chronic alcoholics. 136
Guillain-Barré syndrome associated with SARS-CoV-2 129
Bioimpedance Phase Angle as a Prognostic Tool in Late-Onset Pompe Disease: A Single-Centre Prospective Study With a 15-year Follow-Up 128
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 128
Recombinant alpha-glucosidase in adult-onset type II glycogenosis: The experience with the first Italian patient, from expanded access programmes to marketing authorization 126
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 125
Severe recurrent myelitis in patients with hepatitis C virus infection 124
Early-onset ptosis in type II glycogenosis 123
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patientswith Alzheimer's disease and vascular dementia. 123
NMO-IgG-negative relapsing myelitis 122
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 122
Clinical MRI dissociation in myelopathy: a clue to sarcoidosis? 121
Aspetti clinici e patogenetici della comorbidita’ emicranica. 121
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 121
The angiotensin-converting enzyme insertion/deletion polymorphysm modifies the clinical outcome in patients with Pompe disease. 120
Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encphalomyelitis. 119
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 119
Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD) 118
Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. 117
Immune-mediated neuropathies in myeloma patients treated with bortezomib. 117
Genotype-phenotype correlation in Pompe disease, a step forward. 116
Emicrania emiplegica familiare: dalla genetica alla clinica. 115
Efficacy of propafenone in paramyotonia congenita 110
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants 110
Combined central and peripheral demyelination: comparison of adult and pediatric series 109
Severe recurrent myelitis in patients with hepatitis C virus infection patients 108
Strabismo parossistico: Meccanismi corticali e meccanismi periferici nella fisiopatologia di due casi con analoga fenomenologia critica 108
Can genes influencing muscle function affect the therapeutic response to enzyme replacement therapy (ERT) in late-onset Type II Glycogenosis? 107
Enzyme replacement therapy in severe adult-onset glycogen storage disease type II 107
Outcome after Two Years of Enzyme Replacement Therapy (ERT) in 29 Patients with Late-Onset Type II Glycogenosis (GSDII) 105
Triggering migraine attacks:the role of nitroderivatives. 104
Pathogenetic role of myelitis for syringomyelia. 103
Recombinant alglucosidase alpha (rhGAA) in adult-onset type II glycogenosis (GSDII): A follow-up study before and after treatment 103
RECOMBINANT ALGLUCOSIDASE ALFA IN ADULT-ONSET GLYCOGENOSIS TYPE II: A FOLLOW-UP STUDY BEFORE AND AFTER TREATMENT 97
Enzyme replacement therapy in adult-onset type II glycogenosis 97
Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease. 94
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 94
Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? 93
Presyrinx in children with Chiari malformations 92
Trunk muscle involvement in late-onset Pompe disease: Study of thirty patients 87
Familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2 87
Retinal migraine as unusual feature of cerebral autosomal dominantarteriopathy with subcortical infarcts and leukoencephalopathy(CADASIL) 85
Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? 83
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. 83
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review 83
Ocular neuromyotonia with both tonic and paroxysmal components due to vascular compression 82
Enzyme replacement therapy in late-onset type II glycogenosis. 81
Post-infectious and postvaccinal acute disseminated encephalomyelitis occurring in the same patients 78
The diagnosis of migraine: clinical and instrumental aspects 77
ENZYME REPLACEMENT THERAPY IN LATE-ONSET PHENOTYPES OF GLYCOGENOSIS TYPE 2: RESULTS OF AN ITALIAN MULTICENTER STUDY 75
Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful? 75
Erectile dysfunction as a sentinel symptom ofcardiovascular autonomic neuropathy in heavy drinkers 74
Post-infectious inflammatory disordes:sub-groups based on prospective follow-up. 74
Severe steroid-resistant post-infectious encephalomyelitis: General features and effects of IVIg 73
COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up 65
Enzyme replacement therapy with Alglucosidase alfa in juvenile-adult glycogenosis type 2 patients 57
Guillain‐Barré syndrome and COVID‐19: A 1‐year observational multicenter study 40
null 34
MYBPC1-associated congenital myopathy with tremor: further delineation of the clinical and pathological phenotype in the first Italian case 23
Quantitative MRI Biomarkers for Early Muscle Involvement in Late Onset Pompe Disease 20
Dynamic MR of Muscle Contraction During Electrical Muscle Stimulation: Potential Application to the Evaluation of Neuromuscular Diseases 16
Dropped Head Syndrome Unmasking Myotonic Dystrophy Type 1 in a Patient with Parkinson's Disease: A Case Report and a Case‐Based Review 14
Totale 7.193
Categoria #
all - tutte 30.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022206 0 0 0 0 0 4 3 11 11 2 36 139
2022/20231.202 84 90 12 174 97 123 2 61 438 13 96 12
2023/2024398 49 73 11 18 28 102 5 26 5 10 19 52
2024/20251.113 34 96 60 31 35 74 68 51 248 42 105 269
2025/20262.343 209 203 260 220 286 109 452 91 232 137 81 63
2026/2027577 45 135 129 257 11 0 0 0 0 0 0 0
Totale 7.193